Mutations that inactivate the retinoblastoma (Rb) pathway are common in human tumors. Such mutations promote tumor growth by deregulating the G1 cell cycle checkpoint. However, uncontrolled cell cycle progression can also produce new liabilities for cell survival. To uncover such liabilities in Rb mutant cells, we performed a clonal screen in the Drosophila eye to identify second-site mutations that eliminate Rbf Ϫ cells, but allow Rbf ϩ cells to survive. Here we report the identification of a mutation in a novel highly conserved peptidyl prolyl isomerase (PPIase) that selectively eliminates Rbf Ϫ cells from the Drosophila eye.
A N important goal of novel cancer therapy is to elicit mutations in the RB1 locus itself, but do carry mutations that target the pathway through the loss of cyclin-depenthe death of mutant tumor cells in the patient, while allowing normal cells to survive. The identification dent kinase (Cdk) inhibitors or overexpression of Cyclin D1 or Cdk4 (reviewed in Sherr and McCormick 2002) . of gene products required for tumor cell survival can provide highly validated drug targets for the developAdditionally, the transforming activities of DNA tumor virus oncoproteins are mediated via their interaction ment of therapeutic inhibitors. Ideally, targets could be identified that would kill cancer cells while sparing with RB1 (Helt and Galloway 2003) . The RB1 protein acts as a critical regulator of G1/S normal cells. A synthetic lethal screen is one method of identifying such targets. In this type of screen, cells phase progression by binding to members of the E2F are genetically altered to model tumor cells and one family of transcription factors (Dyson 1998 ; Nevins then screens for mutations that eliminate the model 2001). E2F-RB1 complexes prevent entry into S phase tumor cells but have little or no effect on wild-type cells.
by actively repressing transcription through the recruitOne way to model tumor cells is to functionally inactiment of histone deacetylases and other chromatin modvate the RB1 gene. In addition to being mutated in ifiers to E2F-responsive promoters (Harbour and Dean retinoblastomas, where it was initially discovered, RB1
2000; Ogawa et al. 2002) . Progression from G1 through is mutated in many other cancers including prostate S phase occurs when RB1 is inactivated through phos- , bladder (Miyamoto et al. 1995) , phorylation by the Cdk complexes Cyclin D/Cdk4 or parathyroid (Cryns et al. 1994) , and 90% of small cell Cyclin D/Cdk6 and Cyclin E/Cdk2 (Lundberg and lung cancers (SCLCs) (Minna et al. 2002) . RB1 is also Weinberg 1998). Phosphorylation relieves transcripfunctionally inactivated in tumors that do not harbor mutant proteins. The mutation analysis of the Rbf transcripts revealed an 11-bp deletion resulting in a frameshift at amino acid residue 519, followed by the addition of 14 novel residues and truncation of the Rbf protein at residue 533. The truncated protein lacks Pocket B, a highly conserved RBF domain that is required for interactions with partner proteins and the execution of RBF function. (B) Diagram of the Rbf rescue construct and Rbf Ϫ clone generation. The Rbf SLS-15 mutation combined with a Rbf rescue construct allows for the generation of Rbf Ϫ clones specifically in the eye, due to eye-specific FLP expression followed by recombination between the FRT sites and subsequent loss of the Rbf ϩ and w ϩ genes. All other tissues, which do not express FLP, remain Rbf ϩ , resulting in a rescue of the organismal lethality normally associated with Rbf -deficient flies.
tional repression and allows E2F-dependent transcripity on their own due to their function in essential tissues or cell types. An additional complication in the case of tion of target genes required for S phase progression, such as Cyclin E (Morris et al. 2000) as well as enzymes Rbf is that it itself is required for embryonic survival.
To circumvent this issue, we generated mosaic animals required for DNA synthesis and metabolism (Stevaux and . In addition to its effects on cell prolifthat carry clones of Rbf Ϫ tissue in the eye, whereas the rest of the animal is Rbf ϩ . We then generated overlaperation, loss of RB1 predisposes cells to apoptosis through the actions of E2F on p53 (reviewed in Chau and Wang ping clones of homozygous induced mutations in the eye and screened for potential synthetic lethality by 2003), thereby creating a selective pressure for tumors scoring for the absence of clones carrying both the into accumulate mutations in p53. duced mutation and the Rbf Ϫ mutation. We report the Components of the RB1 pathway are being investiidentification of a mutation in a novel highly conserved gated as potential anticancer targets. These include the peptidyl prolyl isomerase that preferentially eliminates upstream kinases, Cdk2, Cdk4, and Cdk6, and the downRbf mutant cells. stream effector of retinoblastoma (Rb), E2F (McLaughlin et al. 2003; Vermeulen et al. 2003) . These targeted approaches could lead to therapies with an improved MATERIALS AND METHODS profile of efficacy vs. toxicity compared to conventional treatment. It would also be of interest to identify novel Drosophila stocks and handling: All fly stocks and crosses targets involved in RB1 biology, especially those neceswere handled using standard procedures at 25Њ. Rbf alleles and rescue lines used in this study have been deposited at the sary for the viability of cells mutant for RB1. We thereBloomington Drosophila Stock Center. Rbf (Figure 1A) fore carried out a synthetic lethal screen in Drosophila was generated in a suppressor screen as being able to reverse to look for RB1-interacting genes. (Xin et al. 2002) 
TGGACGAAGAGCATCAGGG) and Neo2Ra (CGATACCG Progeny were scored for the absence of w tissue in the eye, leaving the w ϩ (Minute) tissue to populate the eye. Candidate TAAAGCACGAGGAAG). The isogenic arm was then recombined onto the FRT line by monitoring the absence of w ϩ mutations that resulted in the elimination of 90% of the w tissue were selected for further testing and crossed to balancer and the presence of the FRT by PCR. Males also carried an exogenous source of ey -FLP on the non-FRT autosome to stocks. Five of the resulting progeny were subsequently retested to ensure the passage of the mutation and the validity create more robust homozygous clones than those produced by the PExp{FRT2.
of the phenotype. Counterscreen: Individual modifiers were subsequently Primary genetic screen: Males were mutagenized by feeding them 5 mm EMS for 20-24 hr (in a 1% sucrose solution) after mated to a corresponding counterscreen stock (Rbf ϩ , Minute-FRT, w ϩ lines: MFRT2R, MFRT2L, MFRT3R, and MFRT3L) a 4-hr starvation period. Batches of 40 mutagenized males were mated to 30-50 virgin females ( Figure 2A ). The low and assayed for w tissue viability in the eye to demonstrate a specific interaction dependent on Rbf Ϫ ( Figure 2B ). Con-EMS concentration was determined to induce only 0.8 lethal mutations per autosomal arm, which was essential to the sucfirmed synthetic modifiers were stocked over CyO or TM6B balancer chromosomes. cess of identifying synthetic loci, since any additional mutations that caused cell lethality would have led us to discard Genetic mapping of modifiers: Only synthetic lethal modifiers that were also homozygous organismal lethal were the hit during the counterscreen. The mutagenesis rates for each round were confirmed by monitoring the segregation mapped. Recombination mapping of the synthetic lethal phenotype was conducted using al 1 dp ov1 for hits on the third chromosome and selecting for recombiAdditional mutagenesis was performed via gamma-ray irradiation at 1.625 krad using a Cobalt-60 source Gammacell 220 nants that retained a FRT. A copy of ey -FLP (EFL2 or EFL3) was crossed in and recombinants were scored for organismal Irradiator. Crosses were flipped daily for 3 consecutive days. Rbf ϩ screening-stock virgin females were crossed to mutagenized male stocks. Male progeny were assayed for mutations that resulted in the loss of w eye clones, causing the eyes to be w ϩ . Two separate FLP/FRT recombination events are initiated by the eyeless promoter. First, the FRTs flanking the Rbf rescue construct recombine in cis, eliminating the Rbf ϩ and w ϩ genes, resulting in a large Rbf Ϫ , w clone in the eye. Second, the trans recombination between the two autosomal FRTs results in the generation of three different cell types: lethality and synthetic lethality (Table 3 ). The organismal stocked over marked CyO-GFP balancer chromosomes (Table lethal phenotype was further mapped using deficiencies ob-1). Triplicate groups of 10 third instar larvae negative for GFP tained from the Bloomington Stock Center and deficiencies were collected from isoFS2R, KE1-1, and KE1-2 animals (Table  created by Exelixis (Parks et al. 2004 ) that span the region 1). Total RNA was collected using QIAGEN's (Valencia, CA) identified by the recombination mapping ( Pfam scores Ͼ0 and E -values Ͻ1 were used in the analyses. used to amplify the regions of interest, using genomic DNA All sequences data mined were analyzed against the fly genome prepared from five individual larvae (large larvae in the case to select those with top BLAST scores to CG3511 and not to of homozygous mutants or the parental mutagenized strain another fly protein sequence. Those meeting BLAST requirefor controls). Using this procedure, we were able to obtain ments were termed orthologs. All mined sequences that conhigh-quality fragments of genomic DNA up to 10 kb in length, served the PF00400 and PF00160 domain organization met although the usual product length was ‫7ف‬ kb. Products were orthology criteria, while none of the PF00160 only sequences amplified for 30 cycles using a modified long-range PCR protodid. Sequence alignments were performed using Clustal W col with Takara (Berkeley, CA) LA Taq polymerase, checked and visualized by a tree diagram for multiple sequence alignon agarose gels, and purified with the Millipore (Bedford, ments or by BOXSHADE for pairwise alignments. MA) MultiScreen PCR cleanup kit. Purified PCR products were used as templates for sequencing, using the abovedesigned staggered sequencing primers and primer walking in both directions to obtain full-length sequence. ABI (Colum-RESULTS bia, MD) BigDye sequencing reactions were performed according to manufacturer's protocol using 20-80 ng PCR prodStock generation and synthetic lethal screen: Inactiuct. Reactions were ethanol precipitated and loaded onto an vating mutations in Rbf were isolated in a suppressor ABI 3700 sequencer. Sequencing traces were uploaded to a screen for genes able to overcome the G1 arrest caused (B) Schematic of the counterscreen. To eliminate those mutations that are not dependent upon Rbf status, hits from the primary screen were crossed to Rbf ϩ MFRT line virgins. The FRT/FLP recombination events under the direction of the eyeless promoter result in the generation of three different cell types: (1) M/M, as described above; (2) M/*, as described above; and (3) */*, if the previously observed synthetic lethal phenotype is indeed Rbf Ϫ specific, this cell type will be able to populate the eye in a Rbf ϩ background, resulting in a w eye. Conversely, if these cells are absent, resulting in a w ϩ eye, then there is no Rbf Ϫ synthetic interaction and the previously observed phenotype was due to nonspecific cell lethality. Recombinants bearing the visible chromosomal markers shown in column 1 were scored for synthetic lethality with Rbf Ϫ in eye clones (column 2), organismal lethality as homozydeletion resulting in a frameshift mutation at amino gotes (column 3), and the presence of the large larva phenoacid residue 519 and the addition of 14 novel residues type as homozygotes (column 4). Y, the phenotype is present; before ending at residue 533 ( Figure 1A ). This gener-N, phenotype absent. [ *], portion of mutant chromosome.
ates a truncated protein lacking the highly conserved Rbf-binding pocket, which is required for interactions with partner proteins and RBF function (Helt and Galchromosome plus ey-FLP. These flies were then crossed to the transgenic Rbf screening stock females. ey-FLP loway 2003). Like reported null alleles of Rbf (Du and Dyson 1999; Datar et al. 2000) , our alleles confer emgenerates overlapping clones of both Rbf Ϫ , w (from the screening stock females) and the mutagenized FRT bryonic lethality as homozygous mutations.
To circumvent the requirement for Rbf during develautosome (from males) in the eyes of the F 1 progeny, thereby enabling us to screen for recessive synthetic opment, we constructed a transgenic Rbf ϩ screening strain bearing a FLP-FRT rescue transgene to provide lethal mutations in a single generation. Putative synthetic lethal progeny were identified by the presence of wild-type Rbf to all cells and to mark Rbf ϩ cells in the developing eye with w ϩ ( Figure 1B , Table 1 ). This transsolid red eyes (Rbf Ϫ , M, w ϩ ), indicating that the mutant cells (Rbf Ϫ , w) are absent. We screened through individgenic strain is rescued to complete viability and fertility and generates marked viable clones of Rbf Ϫ , w cells ual progeny from crosses generating mitotic clones on the second and third autosomes, which constitute ‫%08ف‬ where FLP recombinase is expressed. To generate homozygous clones of newly induced mutations in the F 1 of the genome. We screened 342,000 mutagenized chromosomes and initially identified 1585 chromosomes progeny, these flies also carried a FRT at the base of one of the autosomal chromosomal arms in cis to a bearing putative synthetic lethal mutations in combination with Rbf Ϫ (Table 2) , for retest and counterscreening Minute mutation (MFRTs) (Figure 2 ; Lambertsson 1998) to generate the Rbf screening stocks (Table 1) .
in the following generation. To eliminate those mutations that cause cell lethality For the screen, a low frequency of mutations was induced by EMS in w males carrying an autosomal FRT independent of Rbf status, we counterscreened the 1585 Deficiency name or stock number tested is given in column 1. The left-and right-hand cytogenetic locations are given in delay, and organismal lethality all cosegregate with the columns 2 and 3, and the lethality or viability when the defiregion distal to 60C and suggested that a single locus ciency was scored with KE1-1 and KE1-2 is given in column 4.
might be responsible for all the observed phenotypes. Organismal lethality was used for further mapping and revealed that KE1-1 failed to complement an existing chromosomes in Rbf ϩ eye clones induced under similar chromosomal deletion spanning 60C6 to 60D9-10 (Taconditions ( Figure 2B ) and reconfirmed their ability ble 4, BL-2604). Using the targeted deletion strategy to reduce the viability of Rbf Ϫ cells. Ten of the 1585 previously described (Parks et al. 2004) , this large defimutations were found to be bona fide synthetic lethals, ciency was then subdivided into five small overlapping reducing the viability of Rbf Ϫ , but not Rbf ϩ , cells (Table  deletions with molecularly defined endpoints. Only one 2). Nine of these were developmentally lethal and comof the small deletions generated, Df(2)Exel8091 (60D4-plemented one another. One of these 9, on the right 60D14), failed to complement the organismal lethality arm of the second chromosome, was designated KE1-1.
present on the KE1-1 chromosome (Table 5) , placing When homozygous KE1-1 mutant clones are induced in the locus responsible for homozygous lethality between the developing eye in a Rbf Ϫ background, the resulting genomic coordinates 20047526 and 20093250 (FlyBase adult eyes lack the Rbf Ϫ , w clonal tissue (Figure 3, B v4.0). and C). However, when KE1-1 mutant clones are generConfirmation that CG3511 mutations confer the ated in a Rbf ϩ background, the tissue is viable (Figure Rbf Ϫ synthetic interaction phenotype: We sequenced 3D), demonstrating that KE1-1 is homozygous viable in several candidate open reading frames between these cells in the presence of wild-type Rbf. Thus, the lethal coordinates and identified lesions in one open reading interaction is specific to Rbf Ϫ cells, and KE1-1 is a true frame, CG3511, which is predicted to encode a presynthetic lethal mutation. When KE1-1 is homozygous in viously uncharacterized protein with similarities to all tissues throughout development, homozygous larvae cyclophilins. The predicted KE1-1 cDNA contains a pair display an enlarged body phenotype compared to their of missense mutations at nucleotides 569 and 570, folheterozygous KE1-1/ϩ siblings ( Figure 3E ). These "large lowed by a single-base-pair deletion at nucleotide 572 larvae" wander for an extended period before death, ( Figure 4A ). These changes are predicted to cause a although rare escapers can progress to giant pupae that frameshift at amino acid 133 and the early truncation fail to eclose as adults ( Figure 3F ).
of the protein at residue 158 ( Figure 4 , B and C). While To identify the KE1-1 locus, we defined the chromothe mutations in CG3511 confer organismal lethality, somal region sufficient to confer synthetic lethality in proof that this mutation alone was sufficient to cause eye clones using standard recombination mapping with the synthetic interaction with Rbf Ϫ in eye clones revisible markers (Table 3) . This analysis defined a region mained to be shown. We therefore conducted a nonat the tip of 2R distal to sp at 60C as necessary and complementation screen to identify additional mutasufficient to confer the Rbf Ϫ synthetic lethal phenotype. tions in CG3511 and tested their ability to prevent the When homozygous, this chromosomal region also prosurvival of Rbf Ϫ clones ( Figure 5 , materials and methods). From this screen we isolated KE1-2, which also duced a lethal phenotype with large larvae and delayed eyes, confirming that the mutation on the KE1-2 chromosome is sufficient to confer the Rbf Ϫ synthetic phenotype (data not shown). As with KE1-1, recombination mapping using visible markers demonstrated that the Rbf Ϫ -dependent synthetic lethality, large larvae phenotype, and organismal lethality of KE1-2 all cosegregated with the region distal to 60C, containing CG3511. Thus, even though we were unable to define the nucleotide changes in KE1-2 mutants, these mapping data suggest that the KE1-2 chromosome contains a lesion that cosegregates with the same narrowly defined region containing CG3511 and that causes a reduction in the levels of this transcript. The most plausible explanation is that the KE1-2 mutant chromosome bears a lesion in a cisregulatory element in CG3511, and that the observed reduction in transcript levels is sufficient to confer the Rbf Ϫ -dependent phenotype. teins (Smith et al. 1999) . At the carboxyl terminus is a cyclophilin-type peptidyl prolyl isomerase (PPIase) domain. Sequence analysis reveals that CG3511 is 59% displayed the large larva phenotype when homozygous identical overall to its predicted human ortholog, or when in trans to KE1-1 (data not shown). KE1-2 was KIAA0073, and 73% identical within its prolyl isomerase also lethal over Df(2)Ex8091 and BL-2604 (Table 5) , domain ( Figure 4 , B and C). The peptidyl prolyl isoconfirming that KE1-2 likely represents a second allele merase-like (PPIL) proteins are the next most closely of CG3511. Sequencing of the open reading frame of related PPIases, but they lack WD domains and are pre-CG3511 and its adjacent 5Ј region (into CG12252) did dicted to be orthologs of other fly proteins. Single not reveal any mutations, so we analyzed transcript levels CG3511 orthologs are found throughout eukaryotes, in mutant larvae by RT-PCR. Transcript levels of CG3511 including nematode CYP-15 and fission yeast Cyp9. The were reduced Ͼ90% in KE1-2 larvae compared to the inclusion of multiple WD domains distinguishes these parental strain (Figure 6 ). A reduction in transcript unique PPIases from others described to date. levels of ‫%05ف‬ was also observed in homozygous KE1-1 larvae. This reduction in mRNA levels in mutants was specific to CG3511, since transcript levels of adjacent DISCUSSION genes were present at normal levels (data not shown).
We have designed and carried out a screen in which A likely explanation is that the KE1-2 mutant contains overlapping clones of mutant cells are generated in the an aberration in a distant cis-regulatory element controleye in such a way as to allow screening of recessive ling the transcript levels of CG3511. KE1-2 was intromutations for synthetic lethality in the F 1 generation. duced into our screening and counterscreening strains This scheme made it possible to screen through large to test its interactions with Rbf in the eye. Clones homozygous for KE1-2 failed to survive in Rbf Ϫ but not Rbf ϩ numbers of mutations without having to set up individ- Figure 6 .-CG3511 is underexpressed in KE1 mutants. Quantitative analysis of CG3511 transcript levels in larvae is shown. The y-axis shows normalized CG3511 transcript levels (see materials and methods) present in wild-type (IsoFSR), KE1-1, and KE1-2 mutant third instar larvae. The reduction in transcript levels observed in the KE1-2 larvae is Ͼ10-fold. ual lines and therefore allowed for the isolation of the applications in several RB1 pathway-dependent cancers, such as SCLC (Sherr and McCormick 2002) , and may very rare Rbf synthetic lethal mutations.
Peptidyl prolyl isomerases belong to an extended prorepresent a unique opportunity for targeted therapeutein superfamily whose members all catalyze the cis-trans tics. isomerization of proline imidic bonds in polypeptides.
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of the native state, leading to potential effects on protein function and regulation of serine/threonine phosphorylation events (Andreotti 2003; Weiwad et al. 2004) . LITERATURE CITED PPIases have been shown to play diverse functional roles in the cell and some, like Pin1, have been implicated
